Peter Hofland on Muck Rack

Peter Hofland

Verified
United States
Journalist and Medical Writer — Freelance
As seen in: Freelance

Journalist & Medical Writer/Editor - R&D/Life #Science #Biotech #Pharma. Managing Partner InPress Media Group & Sunvalley Communication

Search Tweets

Twitter Feed

@hofland — 142 followers, 518 tweets

U.S. FDA Grants Priority Review for Brentuximab Vedotin in Frontline Advanced Hodgkin Lymphoma – ADC Review  http://sumo.ly/18a7 
PepTalk: The Protein Science Week – New Horizons, New Goals – ADC Review  http://sumo.ly/14ZO 
Interim Phase I Data from ADCT-301 Shows Encouraging Preliminary Safety and Efficacy Results – ADC Review  http://sumo.ly/9z9 
Promising Preclinical Results Show Antibody Effectively Targets CD74 in Lymphoma and Multiple Myeloma – ADC Review  http://sumo.ly/2n2 
GSK2857916 Demonstrates 60% Response Rate in Heavily Pre-treated Relapsed/Refractory Multiple Myeloma Patients – ADC Review https://t.co/3ewv0QIA6K
Show More